7-[4-(4-chlorobenzyloxy) benzenesulfonyl]-8-methoxy-3-methyl-2,3,4,5-tetrah ydro-1H-3-benzazepinium maleate or tosylate as antipsychotics

Details for Australian Patent Application No. 2004293179 (hide)

Owner Glaxo Group Limited

Inventors Clapham, David

Agent Davies Collison Cave

Pub. Number AU-A-2004293179

PCT Pub. Number WO2005/051916

Priority 0327740.7 28.11.03 GB

Filing date 25 November 2004

Wipo publication date 9 June 2005

International Classifications

C07D 223/16 (2006.01) Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom

Event Publications

8 June 2006 PCT application entered the National Phase

  PCT publication WO2005/051916 Priority application(s): WO2005/051916

17 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004293180-Antibodies binding to a C-terminal fragment of Apolipoprotein E

2004293178-Organic compounds